DOI: 10.4244/EIJV14SABA1

Welcome to PCR London Valves 2018: 10th Anniversary Edition

Marco Barbanti1, MD; Bernard Prendergast2, MD; Michael Haude3, MD; Nicolo Piazza4, MD; Stephan Windecker5, MD; Andreas Baumbach6, MD; Corrado Tamburino1*, MD, PhD

Welcome to London for the 10th edition of the world’s largest course focused on the exciting field of transcatheter therapies for valvular heart disease. Throughout the last decade, the course has evolved and expanded considerably, with a dynamic interactive programme provided by a global world-leading faculty and constantly renewed in response to invaluable feedback from over 2,500 course participants. Since the beginning, our constant purpose has been to provide the community with teaching and useful tools to improve the treatment of our patients affected by valvular heart disease.

As is the spirit of all PCR courses, this year PCR London Valves will offer participants a unique opportunity to learn basic and more advanced techniques, while discovering the latest clinical research and technological innovations in the field. Indeed, the course is a perfect mix of didactic and interactive sessions, live cases, new technology demonstrations and late breaking trials.

The EuroIntervention PCR London Valves supplement embodies the spirit and content of the meeting, including highly comprehensive review articles authored by some of the world’s key opinion leaders in the field and tackling some of the “hot topics” in the field of transcatheter heart valve therapies. This year’s supplement has been divided into four sections, “Structural Interventions”, “Aortic Valve Interventions”, “Mitral Valve Interventions”, and “Tricuspid Valve Interventions”. We are certain that this volume will provide a comprehensive source of knowledge to guide your daily clinical activities back home.

This supplement would not have been possible without the enthusiastic participation and support of many extraordinary colleagues and friends who have shared their knowledge and experience. Our gratitude also goes to Patrick W. Serruys and the Deputy Editors of EuroIntervention, for hosting this 2018 PCR London Valves supplement once again, and ensuring that it mirrors the interests and direction of the Course itself.

On behalf of the valve community, we thank you.

Volume 14 Supplement AB
Sep 7, 2018
Volume 14 Supplement AB
View full issue


Key metrics

Suggested by Cory

10.4244/EIJV10I7A136 Nov 20, 2014
PCR London Valves: a very special year
Windecker S et al
free

10.4244/EIJV9SSA1 Sep 15, 2013
Welcome to PCR London Valves 2013
Thomas M and Windecker S
free

10.4244/EIJV13SAAA1 Sep 24, 2017
Welcome to PCR London Valves 2017
Tamburino C et al
free

10.4244/EIJV8SQA1 Sep 30, 2012
Welcome to PCR London Valves 2012
Thomas M and Windecker S
free

10.4244/EIJV12I9A179 Oct 20, 2016
EAPCI: the home for the world’s valvular community
Haude M
free

10.4244/EIJV12SYA1 Sep 18, 2016
Welcome to PCR London Valves 2016: back to the UK
Tamburino C et al
free

10.4244/EIJV10SUA1 Sep 27, 2014
Welcome to PCR London Valves 2014
Thomas M and Windecker S
free
Trending articles
318.3

State-of-the-Art Review

10.4244/EIJ-D-21-00695 Nov 19, 2021
Transcatheter treatment for tricuspid valve disease
Praz F et al
free
116.85

State-of-the-Art

10.4244/EIJ-D-24-00066 Apr 21, 2025
Management of complications after valvular interventions
Bansal A et al
free
108.3

Viewpoint

10.4244/EIJ-E-22-00007 May 15, 2022
TAVI at 20: how a crazy idea led to a clinical revolution
Eltchaninoff H et al
free
91.6

Image – Interventional flashlight

10.4244/EIJ-D-22-00344 Aug 5, 2022
First dedicated transcatheter leaflet splitting device: the ShortCut device
Tchétché D et al
free
72.15

State-of-the-art

10.4244/EIJ-D-22-00627 Feb 6, 2023
Left atrial appendage occlusion
Holmes D et al
free
68.9

State-of-the-Art

10.4244/EIJ-D-24-00992 Sep 15, 2025
Antithrombotic therapy in complex percutaneous coronary intervention
Castiello D et al
free
42.95

State-of-the-Art Review

10.4244/EIJ-D-21-00145 Sep 20, 2021
Robotics, imaging, and artificial intelligence in the catheterisation laboratory
Beyar R et al
free
X

PCR
Impact factor: 9.5
2024 Journal Citation Reports®
Science Edition (Clarivate Analytics, 2025)
Online ISSN 1969-6213 - Print ISSN 1774-024X
© 2005-2025 Europa Group - All rights reserved